The Hidden Dangers of Foreign Stem Cells (what can happen) | Dr. Joy Kong

Dr. Kong has been doing this for 8 years and reports no noticeable changes, but she continues because of her faith in the science showing reversal of cellular aging in animal models. She believes the cells are working even if she doesn't feel it, and she receives comments from others that she looks younger. This highlights that stem cell therapy for anti-aging may not always produce perceptible results, but objective measures might show benefits.

Dr. Kong explains that PRP acts as 'food' for stem cells and provides a matrix that helps them remain in the injection site. The growth factors in PRP also signal repair. She uses this combination for paraspinal injections to cover more fascial layers where pain originates. Practitioners who have used both note that stem cells produce more drastic and longer-lasting results than PRP alone.

Dr. Kong notes that IV stem cells primarily activate the immune system via the spleen, which benefits the whole body including the brain. To enhance brain-specific delivery, they use mannitol to open the BBB and also inject stem cells into the nasal membrane, where they travel along nerves directly into the brain. Exosomes can also be given intranasally for easy brain uptake. This multi-pronged approach aims to maximize cognitive repair.

Dr. Kong mentions exosomes as another tool for brain delivery. Exosomes are derived from stem cells and contain growth factors, mRNA, and other signaling molecules. Intranasal administration allows them to reach the brain directly, bypassing the BBB. This is a less invasive option than IV mannitol.

Dr. Kong explains that even the same cell type (e.g., mesenchymal stem cells) behaves differently depending on its source compartment. By combining cord tissue, cord blood, and amniotic membrane, she aims to capture a wider array of regenerative signals. This approach is based on her research and clinical experience.

Dr. Kong explains that expanding cells in culture not only increases numbers but also reduces their potency, increases inflammatory markers, and heightens rejection risk. She has observed patients who received treatments abroad with large cell numbers and then came to her for native cell therapy with 1/5 to 1/7th the dose, achieving superior results. This suggests that the FDA's restriction inadvertently led to a more effective approach.

Dr. Kong cites research where cord MSCs placed next to glioblastoma cells caused the cancer to die and tumors to shrink, while fat-derived MSCs allowed continued growth. She also notes that cord cells have more growth factors, neuroprotection, longer generational capacity, and better differentiation. This is a paradigm shift: the age and origin of the cell determine its therapeutic and safety profile.

She argues that disease activity and inflammation signal the stem cells to spring into action, so there's no need to put out the fire before bringing the firefighter. However, she acknowledges that a person with widespread inflammation may need more sessions because the cells get distributed to many sites.

She explains that IV delivery activates the immune system, which is crucial for repair, but to get more cells into the brain, they administer a mannitol infusion to temporarily open the blood-brain barrier. Additionally, they inject stem cells into the nasal membrane, where they are taken up by olfactory and trigeminal nerves directly into the brain. Exosomes can also be given intranasally for easy brain uptake.